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4ABBREVIATIONS 
Acitretin 9-(4-methoxy-2,3, 6-trimethyl-phenyl)- 3,7-dimethyl-nona-2,4,6,8- 
tetraenoic acid 
ADH Alcohol dehydrogenase 
AOAC Association of Official Analytical Chemists  
APCI Atmospheric pressure chemical ionisation 
ARAT Acyl:CoA retinol acyltransferase 
CAT Chloramphenicol acetyltransferase  
CE Capillary electrophoresis 
CEC Capillary electro chromatography 
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CRABP Cellular retinoic acid binding protein 
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dpc Days post coitum 
ED Electrochemical detection 
ESI Electrospray ionisation 
EtOH Ethanol 
FCS Foetal calf serum  
FLD Fluorescence detection 
GC Gas chromatography 
GFP Green fluorescent protein  
GSH Glutathione 
HPLC High performance liquid chromatography 
IMH Isomerhydrolase 
IPM Interphotoreseptor matrix 
IRBP Interphotoreceptor retinoid-binding protein 
5IS Internal standard 
IUB International Union of Biochemistry and Molecular Biology 
IUPAC International Union of Pure and Applied Chemistry 
JCBN Joint Commission on Biochemical Nomenclature 
LLE Liquid-liquid extraction 
LOD Limit of detection 
LRAT Lecithin:retinol acyltransferase 
MeOH Methanol 
mLOD Mass limits of detection 
MP Monophase 
MPE Monophase extraction 
MRM Multiple reaction monitoring 
MS Mass spectrometry 
NEM N-ethylmaleimide 
NMR Nuclear magnetic resonance 
OPG Osteoprotegenin 
PCR Polymerase chain reaction 
PEEK Poly ether ether ketone 
PPAR Peroxisome proliferator activated receptor 
PrOH Propanol 
RA Retinoic acid
RAL Retinal 
RALDH Retinal dehydrogenase
RALR Retinal reductase 
RANKL Receptor activator of NF-țB ligand 
RAR Retinoic acid receptor
RARE Retinoic acid responsive element
RBP Retinol binding protein
RDH Retinol dehydrogenase 
RE Retinyl ester
REH Retinyl ester hydrolase 
6ROH Retinol
RP Reversed phase 
RPE Retinal pigment epithelium 
RT Reverse transcriptase 
RXR Retinoic X receptor
SDR Short-chain dehydrogenase/reductase 
SDS Sodium dodecyl sulphate 
SPE Solid phase extraction 
TFA Trifluoroacetic acid 
TMMP-ROH all-trans-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-
nonatetraen-1-ol 
TR Thyroid hormone receptor 
TTR Transthyretin 
UGT Uridine (5'-)diphosphate-glucuronosyltransferase 
UPLC Ultra performance liquid chromatography  
UV Ultraviolet 
VAD Vitamin A deficiency 
VDR Vitamin D receptor 
WAT White adipose tissue 
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INTRODUCTION 
History of vitamin A 
In the year 1906 the British biochemist Frederick Hopkins postulated that foods 
contained essential "growth factors" in addition to proteins, carbohydrates, fats, 
minerals, and water [1]. Six years later, he published a paper with the title 
“Feeding experiments illustrating the importance of accessory factors in normal 
dietaries” [2]. Hopkins received the Nobel Prize in medicine in 1929. In 1911 the 
Polish chemist Casimir Funk discovered that the anti-beriberi (motor neuron 
paralysis, beriberi means “I cannot” in Singhalese) substance in unpolished rice was an amine 
(later identified as thiamine), thus Funk proposed that it should be named vitamine, for "vital 
amine" a growth factor present in food which was essential for life [3,4]. Later it became 
apparent that there was more than one growth factor, and the term vitamine soon came to be 
applied to the growth factors in general. McCollum and Davis, and Osborne and 
Mendel simultaneously discovered that some growth factors could be extracted 
into lipids and divided them into two classes 'fat-soluble A' and 'water-soluble B' 
[5,6]. Objecting to the chemical implications of the suffix '-ine', Drummond later 
suggested deletion of the final 'e', renamed McCollum's two groups vitamin A and 
vitamin B, and proposed that further future members of this series should be called vitamin C, 
vitamin D, etc [7]. 
In 1934 Wald extracted and isolated from the retina of animals a substance he named retinene [8]. 
Morton later suggested that this compound was the aldehyde of vitamin A [9], and called it 
retinaldehyde which later became retinal (RAL) [10].  
The correct structure of vitamin A was deduced in 1931 by Karrer who proposed the 
name axerophthol based on its action in preventing the eye disease xerophthalmia, an 
excessive dryness of the conjunctiva and cornea often leading to blindness [11]. 
Karrer received the Nobel Prize in chemistry in 1937. Since then, numerous closely 
related compounds belonging to the family of vitamin A have been described.  
Paul Karrer
Elmer V. McCollum 
10
Figure 1.  Structures of the 
most common retinoids. 
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Nomenclature of retinoids 
According to the Joint Commission on Biochemical Nomenclature (JCBN), including the 
International Union of Pure and Applied Chemistry (IUPAC) 
and International Union of Biochemistry and Molecular 
Biology (IUB), the term vitamin A should be used as the 
generic descriptor for retinoids exhibiting qualitatively the 
biological activity of retinol (ROH). Retinoids, on the other 
hand, are a class of compounds consisting of four isoprenoid 
units joined in a head-to-tail manner. All retinoids may be 
formally derived from a monocyclic parent compound 
containing five carbon-carbon double bonds and a functional 
group at the terminus of the acyclic portion [12-14]. The 
chemical structures of the most common retinoids are given in 
figure 1, whereas a more comprehensive listing may be found 
in Paper V, figure 1, page 16.
The major forms of vitamin A are ROH, RAL, retinyl esters 
(REs) and retinoic acid (RA). RA contains an ionisable 
carboxylic acid moiety and is soluble in alkaline aqueous 
solution. RE, ROH and RAL are lipophilic compounds with 
limited solubility in aqueous solutions. Most of the retinoids 
have 4-6 double bonds in conjugation, accordingly they 
absorb light very well (İҏ= 40-60 000) in the 300-400 nm 
region. Ultraviolet (UV) detection is consequently often the 
detection principle of choice in retinoid analysis. Each double 
bond can exist in either cis or trans configuration. If all double 
bonds are in trans configuration, the term all-trans is used (e.g. 
all-trans retinol (atROH)). If the double bond between carbon 9 and 10 is in cis configuration the 
name 9-cis ROH (9cROH) is used. A more detailed description of the physiochemical properties 
can be found in Paper V, page 15-18. 
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Intestinal uptake of retinoids  
Vitamin A is a true essential nutrient that has to be supplied through the diet for most animals. 
The natural source of vitamin A is plant carotenoids with pro-vitamin A activity, meaning that 
the molecule has at least one intact ȕ-ionone ring in one end of the molecule, producing at least 
one molecule of vitamin A upon cleavage in the enterocytes of the intestine.  Of the more than 
600 carotenoids present in nature, between 50 and 60 display provitamin A activity, and ȕ-
carotene is the most important and abundant of these. Although an enzyme responsible for 
cleavage of ȕ-carotene was characterised 40 years ago [15,16], until recently it has been 
controversial whether the cleavage follows a central or eccentric pathway.  It is now established 
that both pathways in this key step of vitamin A production actually occur. The central cleavage 
of absorbed  ȕ-carotene [17], producing two molecules of RAL, is catalyzed by 15,15’-mono-
oxygenase (ȕCMOOX) [18] also called 15,15’-di-oxygenase (EC 1.13.11.21),  while the 
eccentric pathway producing ȕ-ionene, ȕ-apo-carotenals and subsequently RAL by ȕ-oxidation,  
is catalyzed by ȕ,ȕ-carotene-9’,10’-dioxygenase [19].  ȕCMOOX expression was recently 
demonstrated to be regulated by RA in enterocytes, indicating a possible feedback regulation of 
ROH production from ȕ-carotene [20]. This enzyme also cleaves lycopene into its corresponding 
apolycopenals. RAL produced in intestinal enterocytes by either pathway will then be oxidized to 
some extent to RA by retinal dehydrogenase (RALDH) [21], but the majority will be reduced to 
ROH by retinal reductase (RALR), esterified to RE by lecithin:retinol acyltranferase (LRAT) or 
acyl:CoA retinol acyltransferase (ARAT), and incorporated into chylomicrons (CMs) [22].  
Alternatively, if vitamin A in the form of preformed RE is ingested (from an animal in which 
REs have been formed from carotenoids as described above), RE is converted to ROH by retinyl 
ester hydrolase (REH) [23] in the intestinal lumen, taken up by enterocytes, bound to cellular 
retinol-binding protein (CRBP) II, reesterified by LRAT or ARAT and incorporated into CMs. 
The CMs are then exocytosed into the lymphatic system carrying the absorbed provitamin A in 
the form of 60-70 % RE  and 20-30 % unchanged ȕ-carotene [24]. 
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Figure 2. Major pathways of retinoid uptake and transport in the body. 
After entering the general circulation, CMs are converted to chylomicron remnants (CMR) with 
most of the RE intact. CMR-RE are mainly cleared by the liver (~75 %) but uptake in 
extrahepatic tissue, through lipoprotein receptors, occurs to some extent [25]. Direct delivery of 
dietary lipoprotein-RE, and not through retinol binding protein (RBP) bound ROH from the liver, 
has recently been shown to be the preferred route for delivery of vitamin A to the developing 
embryo [26], as well as for secretion into milk [27,28]. The mechanisms involved in the 
absorption of dietary vitamin A have recently been reviewed by Harrison [29]. 
Liver storage and plasma transport 
In the liver, parenchymal (hepatocytes) and stellate cells play a central role in vitamin A uptake 
and storage. CMR-RE entering the space between the endothelial cells and the hepatocytes, 
which is called the “Space of Disse”, undergo lipolytic processing and a receptor-mediated 
endocytosis into the hepatocytes where RE is hydrolyzed by REH to ROH.  Within a few hours, 
ROH is transferred from hepatic parenchymal cells to the stellate cells. It has been assumed that 
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RBP was important for facilitating the transport of ROH from parenchymal cells to the stellate 
cells, but disruption of the gene coding for RBP revealed that RE stores were no different from 
that of the wild type [30,31]. CRBP I null type mice [32] on the other hand do not synthesise or 
accumulate RE in the liver, suggesting that CRBP I, and not RBP, is the key mediator of ROH 
transport within the liver.  In stellate cells, the ROH is esterified with long-chain fatty acids, 
predominantly palmitic, stearic and oleic, to form hepatic RE stored in the form of lipid droplets 
[33]. In mammals, the liver stores 50-80 % of the total body vitamin A, with the stellate cells 
holding 90-95 % of this. Although hepatic stellate cells are particularly important for vitamin A 
storage in many animals, interstitial cells and some other cells of organs such as the lungs, 
kidneys and intestines of higher vertebrates may accumulate REs in lipid droplets after ingestion 
of large amounts of vitamin A [34,35]. Such extrahepatic storage of REs may even be an 
important local supply of vitamin A for organs with a huge demand, e.g. RE storage in retinal 
pigment epithelial cells as a prerequisite for normal visual function.
The mechanisms for mobilization of vitamin A from liver stores are not well characterised. ROH 
complexed with RBP is secreted into the bloodstream. Whether the RBP originates from the 
stellate cells or from the parenchymal cells still remains unclear [31,36]. As ROH has limited 
solubility in aqueous blood, the ROH is transported in the blood stream bound to RBP [37]. 
Approximately 95 % of the ROH-RBP complex is again bound to transthyretin (TTR) in a 1:1 
molar ratio, which increases the size of the whole complex considerably, and thereby reduces the 
excretion of ROH into the urine [38-40] and maintains a steady plasma concentration of 1-3 μM.  
In the target tissues, ROH is taken up on the cell surface, probably by a receptor mediated 
mechanism [41], although this has not been clarified as yet. ROH is then oxidized enzymatically 
to RAL by members of the short-chain dehydrogenase/reductase (SDR) family of microsomal 
enzymes including retinol dehydrogenase (RDH)1, RDH5, RDH11, cis-retinol-androgen 
dehydrogenase (CRAD)1, CRAD2, CRAD3 and retSDR1 [42]. The SDRs utilize atROH bound 
to CRBP-I as substrates. CRBP-I acts as a chaperone for retinol and retinal, and directs them to 
these metabolizing enzymes [43]. RAL is then oxidized further to RA by several types of 
RALDH [44,45]. 
RA also circulates in the bloodstream bound to albumin (4-14 nM) [46], which is ~0.5 % of 
circulating ROH levels [47]. It is, however, generally assumed, based on the relatively high levels 
of ROH in tissues and plasma, and the abundance in tissues of enzymes able to oxidize ROH to 
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RA, that in situ oxidation of ROH to RA is the principal route through which tissue needs for RA 
are fulfilled.  Cytoplasmic RA may then diffuse into the nuclei or, as suggested by some studies, 
be translocated by CRABP I and CRABP II to the nucleus, where it can bind to retinoic acid 
receptors (RARs). 
Catabolism of retinoids 
In addition to the RA producing metabolic system, there is a catabolic system that serves to 
remove excess RA from cells and the body. The production of RA from RAL, the “on-switch”, is 
a non-reversible reaction so RA cannot be recycled and stored for reuse. Instead, the RA 
molecule is inactivated by different enzymes, the “off-switch”, and the rate of excretion from the 
body is increased. The modifications known to occur are; oxidation at the 4 position of the ring 
[48], oxidation at C-18 [49], 5,6-epoxydation [50] and glucoronidation [51] (figures 1 and 4). The 
cloning of the enzyme P450RAI-1, also named CYP26A1 [52], provided valuable insights into 
the catabolism of RA. P450RAI produces 4-OH-RA, 4oxoRA, 18-OH-RA and 5,6-epoxy-RA 
from RA [53]. Some of these retinoids activate the nuclear receptors [54], and it has been  
debated whether they have an important function or are merely waste products on their way out 
of the body. Results from experiments using P450RAI-1 knockout mice suggest that the latter 
suggestion is largely correct. Embryos from these mice have shown teratogenic effects, similar to 
those seen in the presence of excess RA. It is, however, possible that these effects could be 
caused by a deficiency in some of the metabolites produced by P450RAI-1, whose roles are 
presently unknown. 
In a publication by Niederreither et al [55], P450RAI-deficient mice were crossed with a Aldh1a2 
(RALDH) deficient strain. RALDH-deficient mice have very low RA concentrations and their 
embryos suffer from severe malformations. If the teratogenic effects observed in the P450RAI-1-
deficient mice had been caused by lack of metabolites normally produced by P450RAI-1, 
absence of both P450RAI-1 and Aldh1a2 in the double transgenic mice should exacerbate the 
malformations. Alternatively, if this theory was incorrect, the malformations should be reduced 
in the double transgenic mice, due to reduced RA production compensating for the reduced RA 
catabolism. The findings of Niederreihter at al were that the teratogenic effects observed with 
P450RAI-1 knockout were almost fully alleviated by disruption of the Aldh1a2 gene in addition 
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to P450RAI. In this way, Niederreither et al elegantly demonstrated that 4oxoRA is primarily a 
waste product from P450RAI-1 type enzymes.  
at ROH
at RAL
at RA
ADHs
SDRs/CRBP-I
RALDH1
RALDH2
RALDH3
CYP26A1, CYP26B1, 
CYP26C1, CRABP-I
at-RA-RAR/RXR
at-ROH glucuronides
CRABP-II
at-RA glucuronides
LRAT/CRBP-I, 
CRBP-II, CRBP-III
at-RE
at-ROH/RBP at-ROH
at-RA
at-RA/alb
at-RA
CRABP-II
at-ROH/CMR
at-EC/CMR
at-RE/CMR
4-oxo-at RA,  4-hydroxy-at RA, 
5,8-epoxy-at RA, 18-hydroxy-at RA
plus many other polar metabolites
at-EC
RPH
Figure 3.  Schematic representation of major pathways for cellular retinoid metabolism and the 
main enzyme families involved. 
Endogenous retinoids in various tissues 
To my knowledge there is no publication listing the retinoid content of all, or at least most, of the 
organs in an animal. Retinoid concentrations in a few organs from mice, rats and humans can be 
found in the literature, typically from control animals used in experiments or as applications in 
methodological papers. A thorough screening of the retinoid levels in mice, rats, chickens, and 
salmon with standardised diets, age and sex would be of value to the field. In table 1, retinoid 
values taken from various sources in the literature, and supplemented with some data from our 
own lab, are shown. 
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Table 1. Mean concentrations and individual variations of retinoids in various tissues 
 from rats, mice and humans. 
Retinoid  Species  
 Mouse Rat Human 
Retinyl esters 
-Serum/plasma (nM) 
-Liver (μmol/g) 
-Kidney (μmol/g) 
-Brain (nmol/g) 
-Testis (μg/g) 
-White adipose tissue (WAT) (μg/g) 
-Lung (μmol/g) 
-Eye (nmol/g) 
-Ovary (nmol/g) 
-Epidimis (nmol/g) 
352±142 a
4.19±0.53 a
0.80±0.17 a
0.52±0.30 a
0.57±0.2 c
0.35±0.1 c
0.6±0.27 c
14.0±6.0 c
24.0±7.0 c
0.5±0.20 c
69.1±8.5 a
0.22±0.02 a
37.4±13.5 a
0.81±0.13 a
352±142 c
78.4±22.3 a
0.29±0.16 a
Retinol
-Serum/plasma (μM) 
-Liver (μg/g) 
-Kidney (μg/g) 
-Brain (μg/g) 
-Testis (μg/g) 
-WAT (μg/g) 
-Thymus (μg/g) 
-Lung (μg/g) 
-Heart (μg/g) 
-Spleen (μg/g) 
-Muscle (μg/g) 
-Eye (μg/g) 
-Bone (μg/g) 
-Uterus (μg/g) 
-Ovary (μg/g) 
0.59±0.04 a
11.0±1.3 a
0.41±0.04 a
0.65±0.44 a
0.14±0.04 c
0.267±82 c
0.16±0.042 c
8.63±5.1 c
0.22±0.09 c
0.92±0.28 c
0.041±0.036 c
1.23±0.012 c
0.049±0.01 c
0.18±0.04 c
1.90±0.45 c
1.81±0.24 a
1.62±0.16 a
12.5±1.3 a
0.81±0.13 a
3.42±0.38 a
1.05±0.38 a
0.13±0.27 d
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-Epidimis (μg/g) 0.208±0.1c
13-cis-4-oxo-RA
-Serum/plasma (ng/mL) 2.44±1.77 
13-cis-retinoic acid
-Serum/plasma (ng/mL)       
-Liver (ng/g) 
-Kidney (ng/g) 
-Brain (ng/g) 
-Testis (ng/g) 
-WAT (ng/g) 
0.32±0.14 a
1.22±0.17 a
0.66±0.15 a
1.26±0.39 b
0.87±0.27 b
0.22±0.09 c
0.39±0.17 a
0.44±0.12 a
1.80±0.97 a
1.41±0.36 a
at-retinoic acid
-Serum/plasma (ng/mL)       
-Liver (ng/g) 
-Kidney (ng/g) 
-Brain (ng/g) 
-Testis (ng/g) 
-WAT (ng/g) 
-Spleen (ng/g) 
1.08±0.33 a
5.55±1.78 a
2.37±0.95 a
1.60±0.27 a
2.8±0.42 b
0.70±0.17 c
0.22±0.08 c
0.66±0.05 a
5.08±0.72 a
4.06±0.84 a
3.85±0.37 a
1.39±0.30 a
15.8±8.3 a
a: Schmidt et al [56] , b: kane et al [57], c: Gundersen et al, own data (not published) mean 
concentration and individual variations from three different animals, , d: Redlich et al  [58] 
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RARE Target Gene
AGGTCAnnnnnAGGTCA
RXR
atRA
RAR
Figure 4. Classical activation of RARE by RA with 
subsequent alteration of gene transcription 
Mechanisms of action of vitamin A  
Gene transcription
RA functions by binding to 
nuclear receptor proteins. The 
nuclear retinoid receptors can 
be divided into two families, 
the retinoic acid receptors 
(RARs) (DEJ) and the 
retinoid X receptors (RXRs) 
(DEJ), both belonging to the 
steroid hormone superfamily 
of nuclear receptors. These receptors are ligand-dependent transcription factors that regulate the 
expression of numerous genes by binding to sequences of DNA called RA responsive elements 
(RAREs) close to the target genes, thereby altering their transcription [59] (fig 3). RAREs consist 
of direct repeats of the consensus half-site sequence “(a/g)g(g/t)tca” separated most commonly by 
five or two nucleotides (DR5 and DR2, respectively), whereas RXRs are typically separated by 
one nucleotide spacing (DR1) [60]. 
 The receptors mainly mediate their effect via heterodimers (RAR-RXR), but homodimers (RXR-
RXR) have also been described. RXRs also form heterodimers with other members of the nuclear 
receptor family like peroxisome prolifeator activated receptor (PPAR), vitamin D receptor (VDR) 
and thyroid hormone receptor (TR) [61]. It is assumed that RARs need to be activated by a 
ligand, while a RXR can also function as a silent partner, stabilizing the heterodimers. Members 
of the RAR bind, and are experimentally activated to various degrees, by a number of retinoids, 
including atRA, 9cRA, atddRA, at4oxoRA, at4oxoROH and at4oxoRAL. atRA is regarded as the 
physiological ligand in mice and humans, while both atRA and at-ddRA are important in 
chickens. Members of the RXR family have been experimentally activated by 9cRA, 9-cis-3,4-
didehydro RA (9cddRA) and 9c4oxoRA [62-64]. It has, however, been difficult to demonstrate 
the existence of 9cRA in vivo [65-67]. 
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Light hits a rod cell and 
isomerizes retinal
Rhodopsin converts to 
metarhodopsin II
Metarhodopsin II activates 
transducin
Transducin activates 
phosphodiesterase
phosphodiesterase  
hydrolyzes cyclic GMP
cyclic GMP is scarce, so Na+ 
channel closes
An electric impulse is sent to 
the brain
The membrane is 
hyperpolarized
Fig. 5   Flowchart outlining the 
major steps in the vision signal 
transduction cascade  
In addition to the binding of ligands, RARs recruit a multitude of positive and negative regulatory 
proteins, referred to as co-activators or co-repressors, to carry out various transcriptional 
functions. These co-factors serve as bridges between the nuclear receptors and the basal 
transcription machinery [68,69].  The net effect may either be gene repression, the release of gene 
repression, or gene activation. For a detailed description of this topic, see a comprehensive 
review by Perissi and Rosenfeld [70]. Important knowledge about the roles of the various RARs 
and RXRs has been obtained from studies in mice, where one or several of the receptor genes 
have been deleted from their genomes. Interestingly, many, but not all, symptoms of vitamin A 
deficiency (VAD) can be recapitulated in such mice [71]. When mutations only affect one 
receptor, the mice survive and abnormalities are limited, suggesting a functional redundancy 
between various receptors and isoforms. In double knock-outs, lacking either two RAR subtypes 
or both RAR and RXRĮ, the abnormalities are more severe and the animals die [72].  Altogether, 
more than 500 genes have been suggested to be regulatory targets of RA.  
In some cases the regulation of these genes is direct, driven 
by a liganded RAR-RXR heterodimer bound to a DNA 
response element. In many cases, however, the gene 
regulation appears to be indirect, reflecting the actions of 
intermediate transcription factors, non-classical associations 
of receptors with other proteins, or even more distant 
mechanisms. Twenty-seven genes are unquestionably direct 
targets of the classical RAR-RXR-RARE pathway in 
permissive cellular contexts and approximately 100 other 
genes appear to be good candidates [73]. 
Visual chromophore
Vitamin A plays a pivotal role in vertebrate vision [reviewed 
in [74]] and its function in the visual cycle is executed via a 
non-genomic mechanism. The retinoids involved are atREs, 
11cREs, atRAL, 11cRAL, atROH and 11cROH. The ability of the polyene chain of the retinoids 
to change confirmation from cis to trans and visa versa over the different double bonds is crucial 
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in this respect. The outer rods and cones of the retina, located at the hind wall of the eye, contain 
an apoprotein called opsin. This apoprotein is connected by a Schiff base linkage to 11cRAL. The 
complex in rods is called rhodopsin, while other opsins are expressed in cones. The rods function 
is to generate black and white images in dim light, whilst the cones, constituting only 5 % of the 
retina photoreceptors, generate colour images in daylight.  
The initial step in the generation of a visual image in the brain, is the isomerization of 11cRAL to 
atRAL, as incoming light reflected from the visual object hits RAL and causes a cis trans
isomerization. The trans-RAL is a longer molecule than 11cRAL and fits differently in the 
binding pocket of opsin. The pocket is no longer optimal for the RAL molecule and it is expelled 
from the protein, yielding free opsin plus free atRAL. As the protein changes its conformation, it 
initiates a cascade of biochemical reactions (figure 5) that result in the closing of Na+ channels in 
the cell membrane, creating a polarization across the plasma membrane. An electrical impulse is 
passed along the optic nerve, to the brain, where the visual information is interpreted [75].  
Figure 6. Schematic presentation of our current understanding of the rod visual cycle. 
Reproduced and updated from [76]. 
all-trans-
Retinyl palm 
Rpe65 CRBP
All-trans-
Retinol 
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The 11cRAL is then recycled back to atRAL, so that it can be reused in the same process over 
again. This process, referred to as the visual cycle (figure 6), is a complex process involving the 
photoreceptors, several forms of vitamin A, isomerases, hydrolases, reductases and vitamin A 
binding proteins. The regeneration starts with reduction of atRAL to atROH in the outer rod 
segments. The ROH is then transported to the extracellular space surrounding the photoreceptors 
(interphotoreseptor matrix (IPM), subretinal space) where it is taken up by interphotoreceptor 
retinoid-binding protein (IRBP) [77]. The ROH is then translocated to the retinal pigment 
epithelium (RPE), transverses the membrane and it is escorted to LRAT by CRBP. After 
esterification to atRE by LRAT, 11cROH is formed by an isomerhydrolase (IMH) [78]. The 
conversion of atRE to 11cROH was recently found to be dependent on a RE binding protein 
named Rpe65 [79]. Rpe65 is thought to deliver the highly lipophilic RE to IMH. The Rpe65 
knockout accumulates RE in the RPE and 11cROH is absent [80]. Recently, it was demonstrated 
that RPE65 is in fact the IMH in the retinoid visual cycle [81,82]. 11cROH is then oxidized to 
11cRAL by the alcohol dehydrogenases (ADHs) RDH4/5 or 11-cis dehydrogense (RDH11). 
Finally the generated 11cRAL re-enters the rods to re-associate with opsin, forming rhodopsin, 
and the circle is closed [76,83]. 
In the retinas of chickens and ground squirrels, cones represent ~60 % of the photoreceptors. The 
less researched cone visual process has recently been studied in greater detail by Mata and 
colleagues [84-86] and differs from the rod cycle in two main respects. atROH is not transported 
to the RPE, but to the Müller cells were the atROH conversion to 11cROH occurs. 11cROH is 
then transported to the cones, presumably by IRBP, and oxidized to 11cRAL by a novel cone-
specific dehydrogenase that regenerates the chromophore up to 2000 times faster than in the rods 
[85].
Function of vitamin A 
Vitamin A plays an important role in a vast number of physiological processes, including 
reproduction, bone growth, immune function, vision, embryonic development, cell growth and 
differentiation [22]. RAL is the functional form of vitamin A in the visual process, while the 
multitude of remaining functions are so far believed to mediated through RA. Good health 
depends on maintaining vitamin A levels within a normal range, as either too little or too much of 
this vitamin leads to serious disease. Because the liver stores rather large amounts of vitamin A, 
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deficiency states typically take several months to develop. Nevertheless, VAD (hypovitaminosis 
A) is a public health problem in 118 countries, especially in Africa and South-East Asia. 
Globally, between 100 and 140 million children are assumed to be vitamin A deficient [87] and 
VAD contributes to the death of over 1 million children every year [88]. 
Cases of excessive amounts of vitamin A are more rare, but have been known to occur as a result 
of intake of foods particularly rich in vitamin A, like liver from arctic animals, use of 
pharmaceutical preparations, or excessive intake of vitamin A supplements [89,90]. Vitamin A 
toxicity (hypervitaminosis A) in adults manifests itself as one or several of the following 
symptoms; red blood cell damage, abdominal cramps, blurred vision, irritability, bone pain, loss 
of appetite, diarrhoea, nosebleeds, growth retardation, hair loss, skin rashes, dry skin, 
enlargement of the liver, nausea, vomiting, headache and increased cerebrospinal pressure. In a 
recent metaanalysis [90] of case reports on toxicity claimed to be induced by excessive intake of 
vitamin A (ROH or RE), 248 cases published in the scientific literature were identified. The 
authors reported that water-miscible, emulsified, and solid forms of ROH supplements are more 
toxic than oil-based preparations and vitamin A in foods [91]. Use of preparations containing 
various forms of RA (Accutane/Roaccutane, Acitretine/Soriatane) during pregnancy often result 
in miscarriage or severe embryonic malformations [92-96]. More than two million prescriptions 
of these drugs are given every year and during recent years Roaccutane (13cRA) has been 
associated with depression, anxiety and suicide ideation as well as impaired night vision [97-
103]. 
Vision
Vitamin A, in the form of RAL, is a necessary structural component of rhodopsin, the light 
sensitive pigment within the rods of the retina. Related opsin proteins, with covalently bound 
RAL, are found in the three types of cone cells, which are responsible for colour vision.  If 
inadequate quantities of vitamin A are present, vision is impaired. Moderate deficiency leads to 
deficits in vision under conditions of low light ("night blindness"), while severe deficiency can 
result in excessive dryness and opacity of the cornea (xerophthalmia) and subsequently blindness. 
An estimated 250 000 to 500 000 vitamin A-deficient children become blind every year, half of 
them dying within 12 months of losing their sight (WHO 2003) [87]. 
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Immunesystem
The immune system is highly dependent on a sufficient supply of vitamin A to function properly. 
In several infectious diseases studied, VAD has been shown to increase the frequency and 
severity of disease. Additionally, infections will increase the risk of VAD yet further. Population-
based studies have shown that vitamin A supplements decrease the risk of death from infectious 
diseases [104-106]. Vitamin A is essential to maintain intact epithelial cells in the surface linings 
of the eyes and the respiratory, urinary, and intestinal tracts. Lack of vitamin A leads to 
dysfunction - the skin becomes keratinized and scaly, mucus secretion is suppressed and bacteria 
can more easily penetrate the epithelia and enter the body. VAD decreases T-lymphocyte 
mediated antibody responses in mice [107], rats [108] and humans [109]. VAD weakens T-helper 
cell type 2 (Th2) immune responses, while enhancing T-helper cell type 1 (Th1) responses, by 
decreasing and increasing the number of the two cell types respectively [110]. 
Bone growth
Normal functioning of the osteoblasts and osteoclasts of bones, is dependent upon vitamin A. 
Deficiency can result in bone malformations. On the other hand, in recent years too much vitamin 
A has been linked to bone loss and an increased risk of hip fracture [111-113]. In vitro, vitamin A 
increases osteoclast proliferation and activity, and stimulates bone resorption [113,114]. Several 
nuclear RARs are expressed in osteoblasts, but it still is uncertain whether the bone-resorptive 
effect of atRA is mediated via any of these receptors [115-117]. Recently, expression of two of 
the regulatory components in the paracrine signalling necessary for osteoclast differentiation, (i.e. 
osteoprotegenin (OPG) and receptor activator of NF-țB ligand (RANKL)), were shown to be 
affected by atRA through a RAR-mediated mechanism [118]. 
Reproduction
Normal levels of vitamin A are required for several aspects of reproduction. Vitamin A is 
required for spermatogenic epithelial (Sertoli) cells. VAD results in failure of spermatogenesis 
that can be restored by vitamin A replacement within 10–11 weeks and beyond [119]. Severely 
vitamin A deficient rats ovulate, but the oocytes have been shown to be degenerated, with failure 
of blastogenesis [120]. Cornification of the vaginal epithelium also occurs with subsequent 
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failure of implantation [121]. Vitamin A also seems to play an important role in placenta and 
yolk sac development and maintenance, although its role in these contexts is still rather unclear. 
Preimplantation embryo
The developing embryo crucially requires a well-balanced supply of vitamin A for the proper 
development of the whole range of its organ systems. Both excess and deficiency of RA during 
embryonic development, results in congenital malformations. RA is produced when ROH is 
oxidized by RDH enzymes to RAL and then irreversibly to RA by RALDH enzymes [44,45]. 
These enzyme types have been demonstrated to play an essential role in retinoid signalling and 
show discrete domains of expression during embryonic development [122-124].  
As the sperm approach an egg, it must first migrate through a layer of follicle cells and then bind 
to, and cross, the egg coat (zona pellucida). Finally, the sperm must bind to and fuse with the 
plasma membrane of the oocyte and donate several components, including its chromatin, to the 
oocyte. This fertilized oocyte (zygote), which is a single cell embryo, subsequently undergoes a 
series of divisions, progressing through 2-cell, 4-cell, 8-cell and 16 cell stages, and eventually 
forming a blastocyst. The attachment of the mature blastocyst to the uterus wall ends the period 
known as the preimplantation period, which lasts 3-4 days post coitum (dpc) in the mouse. Prior 
to implantation, the mammalian embryo is probably not supplied with many nutrients by the 
mother. Available knowledge about retinoids and retinoid signalling during the preimplantation 
period is scarce. However, sperm from several species, including rats and humans, have been 
demonstrated to contain both RE, atRA and 9cRA [125,126]. To my knowledge neither human 
nor mouse oocytes have ever been successfully examined for retinoid content. Mohan et el 
examined bovine oocytes and pre-attached blastocysts, fertilized in vitro, for expression of 
mRNAs for RBP, RARD, and RARJ and the RARD and RARJ using RT-PCR [127], as well as  
the expression and spatial distribution of RXRs, ADH-I and RALDH2 using whole mount in situ
hybridization, and immunohistochemistry [128]. Expression of mRNA for RBP, RARD, RARJ,
and of the RARD and RARJ2 as well as transcripts for RXRD, RXRȕ and RALDH2 were 
detected in all stages, from the oocyte to the hatched blastocyst. Strong immunostaining was seen 
for both RARD and RARJ2 proteins. It was later shown that the embryos responded when RA 
was added and were able to produce RA from added ROH [129]. In mouse embyros, only RARD,
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RARȕ and RARJ mRNA have been demonstrated [130]. Exposure of mouse embryos to 10 
μmol/l of atRA at oocyte stage or the blastocyst stage were found to cause different degrees of 
retardation of development and embryonic death [131]. Taken together, there seems to be 
sufficient data to support the fact that the preimplantation embryo has the ability to synthesise 
and make use of RA, but so far no one has been able to clearly demonstrate the presence of RA in 
the preimplantation embryo and it remains unclear whether RA signalling occurs or not. The data 
presented in this thesis support the absence of RA signalling during the preimplantation stage.  
Postimplantation embryo
During gastrulation (6-7 dpc), axes are established within the mouse embryo. Head, tail and 
limbs become defined, and by ten days after fertilization all the organs have begun to develop in 
mice. During this period, there is an increased demand for RA, and ROH is therefore supplied to 
the embryo from the maternal bloodstream through the placenta. RBP plays some role in the 
delivery of ROH [132], but alternative mechanisms are also likely to occur as homozygote RBP 
knockout mice are viable and fertile [30]. Recently it was demonstrated that dietary RE bound to 
lipoproteins is the primary source for the foetus to support embryogenesis, and that RBP bound 
ROH functions more as a backup system in case of dietary vitamin A insufficiency [26]. 
Although RBP seems dispensable, RALDH2, the enzyme responsible for oxidation of RAL to 
RA before E9 (in mouse) seems a requisite as offspring of homozygotic mice deficient in 
RALDH2 (RALDH -/-) die in utero before E10.5 [133].  
In the remaining nine days before birth in the mouse, organogenesis continues and the embryo 
increases in size. Chemical analysis of retinoid content in individual organs at early stages of 
development has proven difficult due to the very limited amounts of tissue. In whole mouse 
embryos, however, the major retinoids present seem to be atROH and atRA, at 6.5-9.5 dpc [134] 
and 9.5-14.5 dpc [65]. At later stages viscera, spinal cord, somites, frontonasal mass + branchial 
arches, forebrain, midbrain, hindbrain, tail bud [65] and limb buds [135] have all been found to 
contain high concentrations of atROH and some atRA. Data on embryonic concentrations of REs 
are very limited. The embryo is known to store REs after implantation of the embryo, and 
vitamin A transport via the placenta has been established. Eckhoff et al found 19.1 ng/g RE at 
11.5 dpc in the mouse [136], while the limbs of the porcine embryo were shown to contain 2-4 
nmol/g at gestation days 22-30 [137]. As the pigment of the eye is developed, atRE and 11cRE 
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become detectable in all species, but prior to implantation of the mouse embryo, there seems to 
be no available data on RE distribution.  
Analysis of retinoids 
For a number of years following the report on the structures of ROH and RAL, 
spectrophotometric, fluorometric and calorimetric methods were the only methods available for 
measuring vitamin A. Of these, the Carr-Price method was, until recently, the official procedure 
of the Association of Official Analytical Chemists (AOAC) for ROH analysis [138] but it is 
seldom used nowadays. ROH and its esters produce a blue colour upon reaction with antimony 
trichloride and the intensity of the colour can be used to estimate the ROH concentration in a 
sample. Limitations cited for this method include rapid fading of the colour, inability to 
differentiate between ROH derivatives, and interference from carotenoids [139].  The use of UV 
absorbance, also known as the Bessey-Lowry method [140], was an accepted procedure for more 
than 50 years [141]. The absorbance of the extract is determined, the ROH is irradiated with UV 
light, and the absorbance is determined again. The difference in absorbance is the concentration 
of ROH in the sample. Furthermore, the intense native fluorescence of ROH bound to RBP may 
be utilized in direct fluorometric methods. Serum or plasma analysis based on this technique 
appeared in the literature as late as 1997 [142]. As no sample preparation is needed at all, these 
techniques are quite interesting, even today, and especially for screening large series of samples 
[143,144]. Direct fluorometry on plasma/serum correlates quite well (R=0.7-0.85) with 
chromatography-based methods, but intensity of the fluorescence is strongly affected by the 
degree of hemolysis and turbidity caused by lipaemia in the sample [142,145] .
Around 1950 various chromatographic techniques were developed for vitamin A analysis of 
biological samples. Chromatography is not a measuring technique in itself, but a separation 
technique used in front of a measuring device, the detector. The use of chromatography in 
retinoid analysis will be described more thoroughly in the next chapter. The topic has been 
reviewed by experts on several occasions [146-149]. Paper V in this thesis is a recent 
comprehensive review on the topic, and covers the period from 1995-2001 [150].  
Gas chromatography (GC) techniques are rarely used for vitamin A analysis as there are several 
problematic issues, including dehydration and isomerisation related to the inherently high 
temperatures used, and the high chemical activity of the silica-based stationary phases in the GC 
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columns. Stable isotope tracer techniques, however, based on GC-mass spectrometry (MS) is an 
important tool for studying the bioavailability and bio-efficacy of dietary carotenoids [151]. A 
few capillary electrophoresis (CE) [152-154] and electro chromatography (CEC) [155] based 
methods have also been reported, but have found little use.   
Reporter assays, with RAREs (figure 4) upstream of genes expressing proteins (reporter 
proteins), that can be visualized, developed or detected in some way when RA or other RARE 
activating substances are present have been described [156].  The most common reporters are 
chloramphenicol acetyltransferase (CAT), LacZ (beta-galactosidase), green fluorescent protein 
(GFP) and luciferase.  For example, when LacZ-producing cells are treated with the substrate X-
gal (5-bromo-4-chlor-3-indolyl-ȕ-d-galactopyranoside) they will display a dark blue staining in 
areas expressing the reporter gene, as LacZ catalyses the conversion of the colourless X-gal to the 
deep blue 5,5’-dibromo-4,4’-dichloroindigo in the presence of O2.  If a RARE is used as the 
promoter, staining indicates that RA or another compound with ability to bind and activate RAR-
RXR is present. 
Reporter constructs can be expressed in different cell types and used as an indirect method for 
quantification of retinoids. Pieces of tissue or whole embryos are placed on a layer of cells to 
detect active substances released from the tissue. These reporter systems are very sensitive and 
have given valuable insights on the spatial and temporal distribution of retinoids, but provide 
limited information about the identity and concentration of the retinoid. The assays are limited by 
the facts that the retinoids need to be released from the tissue, that the reporter cells themselves 
can metabolize and isomerise the secreted retinoids, and that retinoids other than the ones 
activating the RARE will not be detected at all. 
By incorporating the reporter gene into the genome of transgenic animals, indications of ligand-
induced activation can be obtained in vivo. However, it should be emphasized that ligand-
independent regulatory mechanisms for nuclear receptor activation, e.g., by phosphorylation 
[157], have been demonstrated and may also be detected by most types of reporter models.
Furthermore, in vivo patterns of activation of reporter genes based on short response elements 
should be interpreted with caution since DNA and chromosome context, and integration site are 
clearly involved in control of gene expression. 
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Liquid chromatographic analysis of retinoids 
Chromatography (meaning “writing in colours” in Greek), was first described by the Russian
botanist Michael Tswett in 1906 [158]. Tswett’s work is relevant in the context of this thesis as 
he applied the technique for the separation of pigments in leaves, the carotenoids, xanthophylls, 
and chlorophyll, some of which have provitamin A activity.  Chromatography has matured 
immensely as a technique during the last hundred years, with high performance liquid 
chromatography (HPLC) initiated in the mid 60s by Horvàth and co-workers [159,160]. The new 
separations techniques were rapidly adopted by biochemists for the separation of various 
constituents of biological samples like steroids and amino acids, as well as vitamin A 
compounds. 
Most biological samples are complex; they contain more than 20 000 different molecules, many 
in mM concentrations, while the concentration of RA usually is in the low nM area. Several 
geometrical isomers of retinoids exist, and interconversion between these are induced by several 
factors including daylight and thiols [161,162]. Additionally retinoids are heat and air sensitive. 
Consequently, successful quantification of retinoids requires extensive clean up and 
concentration, with simultaneous protection from heat, light and air. Furthermore, when 
analyzing biological samples, geometrical isomers sometimes need to be separated in the 
presence of 50-1000 fold concentrations of other retinoids. Therefore accurate quantitative 
measurement of endogenous concentrations of RA in bio-samples is still regarded as an 
especially challenging task.  
The typical procedure for extraction of lipids, including retinoids, from aqueous samples was and 
still is: precipitation of proteins by addition of alcohol, salt or acid; repeated extraction with a 
water-immiscible solvent, such as hexane or ethyl acetate; pooling the supernatants; evaporation 
of the solvent; and reconstitution in a smaller volume compatible with the chromatographic step. 
This manual, laborious, solvent-consuming and lengthy approach often involves use of heat, and 
exposure to light and air - factors that are generally incompatible with the labile nature of 
retinoids, and consequently there is the risk of erroneous results and artifacts. Light exposure can 
be avoided by working under red or yellow light, although these are not ideal working conditions. 
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Solid phase extraction (SPE), a less solvent-consuming, but still manual, technique, has been 
developed but has not been used extensively for retinoid analysis. 
SPE coupled in-line via an automated diversion valve was originally described in 1981 by Roth 
et al for extraction of drugs in bio-fluids [163]. This technique was later adapted by Kraft et al 
[164] and researchers at Hoffman-La Roche in Basel for the analysis of RA and its main 
metabolite, 4oxoRA [165].  This paper was the first to describe the separation of low levels of 
RA and 4oxoRA cis trans isomers in the same run. However a binary gradient, producing a 
severe baseline drift at the end of the run, was needed and the cycle time of the method was 45 
minutes. As the on-line SPE technique may provide full protection from light, heat and air during 
the entire analytical procedure, as well as the possibility of fully automation, we aimed at 
utilizing this technique for retinoid analysis. This technique is challenging and requires advanced 
technical expertise due to the high degree of complexity. It also has a very high initial cost. 
However, if these hurdles can be overcome, a very powerful and flexible analytical tool is 
available.  
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AIM OF THE PROJECT 
The aim of this project was to establish high-throughput chromatographic analytical tools for the 
measurement of endogenous retinoid concentrations in biological samples. As active forms of 
retinoids accumulate in picomolar or low nanomolar concentrations in tissues, it was of particular 
importance to develop highly sensitive methods that would allow detection of very small 
quantities of retinoids in minute tissue samples. In particular, to elucidate the role of retinoids in 
embryonic development, it was important to be able to measure retinoids in early stage embryos 
and small quantities of tissue samples from embryos. Application of the developed methods to 
blood samples in clinical studies will provide insight on the role of retinoic acids in various 
diseases.  Additionally, it was equally important that the developed methods protected and 
conserved the extremely labile retinoids during the sample collection, preparation and analysis. 
Thus, the major objectives can be summarised as follows: 
1. To develop and optimize high-throughput, robust, reliable and very sensitive methods for 
the identification and quantification of retinoids in biological samples. 
2. To use the developed methods to study the distribution of endogenous retinoids in the 
early stages of vertebrate development, blood samples, and other types of biological 
samples. 
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SUMMARY OF RESULTS 
Paper I: Gundersen TE, Lundanes E, et al. Quantitative high-performance liquid 
chromatographic determination of retinoids in human serum using on-line solid-phase 
extraction and column switching. Determination of 9-cis-retinoic acid, 13-cis-retinoic acid, 
at-retinoic acid, 4-oxo-at-retinoic acid and 4-oxo-13-cis-retinoic acid. J Chromatographic B 
Biomedical Sciences and Applications. 1997 Mar 28;691(1):43-58.
In this work, we established a sophisticated, fully automated, two-dimensional, chromatographic 
system with integrated simultaneous sample extraction, concentration and clean up for the 
quantitative determination of trace amounts of endogenous retinoids in plasma or serum. Isocratic 
separation of RA isomers and two 4oxoRA isomers as well as atROH and 13cROH was achieved 
for the first time in the same run, eliminating the baseline disturbances experienced with gradient 
elution. Cycle time was 28 min. Limit of detection for atRA was 23 pmol injected.  Minimal loss 
and artifact generation due to light induced isomerization, air and heat exposure and adsorption to 
glassware during pre-treatment was achieved. The establishment of this initial method was an 
important basis for further development of the chromatographic methods in the Blomhoff lab, 
and in subsequent years was used for the analysis of several thousand samples. 
Paper II: Gundersen TE, Blomhoff R. On-line solid-phase extraction and isocratic 
separation of retinoic acid isomers in microbore column switching system. Methods in 
Enzymology. 1999;299:430-41. 
Extensive experience with the method described in Paper I eventually resulted in the 
development of the next generation of methodology used for retinoid analysis in our lab. 
Quantitative recovery and increased robustness was achieved by precipitation of proteins prior to 
injection, and on-line dilution in front of the SPE column by a third HPLC pump. The inner 
diameter of both the SPE and the separating column was reduced and comparable separation to 
that in Paper I was achieved in less then half the time by optimization of the eluent. Altogether, 
the changes allowed for the quantification of as little as 100 fmol atRA from human serum. As 
well as contributing to higher sensitivity, the reduced cycle time allowed handling of more 
samples. A slightly modified version of this method was later used for analysis of RAs and 
ROHs, as well as 3,4-didehydro retinoids, in chicken embryonic ocular tissues and in mouse 
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embryos. In additional papers, not included in this thesis, the candidate, in collaboration with 
others, explored further possible benefits of reducing the inner diameter to capillary dimensions 
(320 μm) in combination with on-line SPE and column switching [166,167].  
Paper III: Sakhi AK, Gundersen TE, et al. Quantitative determination of endogenous 
retinoids in mouse embryos by high-performance liquid chromatography with on-line solid-
phase extraction, column switching and electrochemical detection. Journal of 
Chromatography A. 1998 Dec 18;828(1-2):451-60.
To increase the method sensitivity further we investigated the potentially very sensitive detection 
technique, electrochemical detection (ED), in combination with the automated column switching 
system. As ED reacts with severe baseline shifts to even small changes in eluent composition, 
gradient elution is not possible and, for the same reason, column switching has rarely been 
attempted. We succeeded in combining the two, resulting in a method with a limit of detection 
for atRA of 33 fmol injected. Isocratic separation of RA isomers was a prerequisite for the 
successful combination. The method was applied to RA analysis in mouse embryos and allowed 
quantification of atRA in a single mouse embryo 9.5 dpc. 
Paper IV: Gundersen TE, Bastani NE, et al. High-throughput analysis of endogenous 
retinoids in human serum using triple stage LC-MS/MS. Manuscript 2006.
In this paper, tandem mass spectrometry (MS/MS) with atmospheric pressure chemical ionisation 
(APCI) and isotope dilution was applied to further improve the identification and quantification 
of retinoids in complex biological samples. MS/MS introduces specificity and sensitivity beyond 
that possible with UV detection. As an additional dimension is used during detection, the 
possibility of contaminated chromatographic peaks is reduced considerably. Sample preparation 
is performed by fast and gentle precipitation with ethanol (EtOH) and direct injection of the 
resulting supernatant. The developed method is slightly more sensitive than the ED system 
described in Paper III, even without the column switching system. By applying modern 1.8 μM 
particle rapid resolution columns, high temperature, high flow, and rapid gradients, we achieved 
the required separation within 6 minutes. This method thus, facilitates robust analysis of 150 
samples per day, including sample preparation. 
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Paper V: Gundersen TE and Blomhoff R. Qualitative and quantitative liquid 
chromatographic determination of natural retinoids in biological samples. Journal of 
Chromatography A. 2001 Nov 23;935(1-2):13-43.  
During the development of the methods described in Papers I-III, considerable experience and 
knowledge about the chemistry, handling and analysis of retinoids were gained. Paper V is a 
detailed tutorial in retinoid analysis and a comprehensive review of the literature published 
between 1995-2001. 
Paper VI: Hoover F, Gundersen TE, et al. Quantitative assessment of retinoid signalling 
pathways in the developing eye and retina of the chicken embryo. Journal of Comparative 
Neurology. 2001 Jul 30;436(3):324-35.
The method described in Paper II was modified to include at-3,4-didehydro ROH (atddROH), 
9cddRA and at-3,4-didehydro RA (atddRA). We studied the developing eye and retina of 
chickens using the HPLC method to quantify biologically active retinoids, 
immunohistochemistry to localize the retinoic acid synthetic enzyme RALDH2, and nucleic acid 
assays to quantify and localize retinoid receptor gene transcripts. Our results demonstrated spatial 
distinctions in retinoid synthesis and signalling that might be related to laminar differentiation in 
the developing retina. RAs, and their precursors ROHs, are the predominant retinoids in the 
developing chicken eye. The retinoid 9cRA was undetectable at all stages. AtddROH was 
detected only in the pigment epithelium and/or the choroid and sclera. RALDH2 
immunoreactivity was intense in the choroid, low or absent in the pigment epithelium, and 
moderate in the neuroepithelium, where it was highest in the outer layers. Transcripts of all five 
chicken retinoid receptor genes were present in the neural retina and eye throughout 
development.  
Paper VII: Ulven SM, Gundersen TE, et al. Identification of endogenous retinoids, 
enzymes, binding proteins, and receptors during early postimplantation development in 
mouse: important role of retinal dehydrogenase type 2 in synthesis of at-retinoic acid. 
Developmental Biology. 2000 Apr 15;220(2):379-91.
In this study we used the method presented in Paper III, and spectrometric detection as well as 
RT-PCR, to identify endogenous retinoids, enzymes, binding proteins, and receptors involved in 
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retinoid metabolism and signalling, in mouse embryos from 9.5 dpc down to 6.5 dpc (the egg 
cylinder stage), the early postimplantation period in mouse. At 9.5, 8.5 and 7.5 dpc atRA, atRAL 
and at ROL were detected along with the retinal generating RDH5, ADH4 and the RA generating 
RALDH2 as well as the retinoid nuclear receptors RAR and RXR. At the 6.5 dpc stage, all of 
these, except atRA and RALDH, were detected. Therefore, our results suggest that RALDH2 is a 
key regulator in initiating RA synthesis sometime between the mid-primitive streak stage and the 
late allantoic bud stage in mouse embryos. 
Paper VIII: Ulven SM, Gundersen TE, et al. Quantitative axial profiles of retinoic acid in 
the embryonic mouse spinal cord: 9-cis retinoic acid only detected after at-retinoic acid 
levels are super-elevated experimentally. Developmental Dynamics. 2001 Nov; 222 (3):341-
53.
In this work we used the method described in Paper III, as well as MS detection and DAD, in an 
attempt to identify definitively the endogenous retinoids present in different regions of the spinal 
cord at the stages when regional differences in RAR and RXR signalling have been reported 
[168]. We found a bimodal distribution of atRA, the ligand for RARs, and related this to the 
expression of several retinoid-synthesizing enzymes. However, we did not detect 9cRA, the 
putative RXR ligand, in any region of the spinal cord unless pregnant mice were gavage-fed 
massive doses of atRA. This study provided the first quantitative profiles of endogenous retinoids 
along the axis of the developing spinal cord. By RT-PCR we also detected transcripts coding for 
several enzymes involved in retinoid metabolism, of which CRAD1, a short chain 
dehydrogenase, and RALDH, were found to be distributed in a bimodal pattern. 
Immunohistochemistry, with antibodies against RALDH, revealed the presence of this protein 
along the entire spinal cord.
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GENERAL DISCUSSION 
Artifacts during sample handling and extraction
It has been a central theme of this work to develop methods that preserve the geometrical 
configuration of the retinoids, by protecting against degrading factors and by using as mild 
conditions as possible. We have developed methods that avoid isomerisations of RAs in plasma, 
serum and embryos of different species.  In the visual cycle, 11cRAL is transformed to the all-
trans form when absorbing the energy from one photon with wavelength below 500 nm. From 
this fact it is evident that light-induced isomerisation of retinoids is a matter of concern. In Papers 
I-III the problems with light-induced isomerisation are minimized by preparing samples in amber 
glassware, using specially designated rooms with red light, and ensuring full light protection after 
protein precipitation by using on-line sample handling and analysis in two-dimensional HPLC 
systems.  
The yellow colour of blood plasma and the red colour of tissue and whole blood provide some 
protection from light. Addition of denaturating solvents will release and expose the retinoids in a 
colourless solution and from this point onwards, extreme care should be taken to avoid exposure 
to light. Concentrated solutions of pure RA isomers have been shown to be reduced to less than 
50 % of initial concentrations upon exposure to daylight [169]. At very low concentrations, the 
degradation rate is even more rapid. Exposure to normal room light for 10 minutes gave mild 
isomerisation of a 50 nM solution of atRA [57]. The light source of the microscope used during 
dissection is normally strong white light. In Paper VI, figure 1, the importance of using suitable 
light conditions during micro dissection of embryonic tissue is illustrated. A 200 pg/ml solution 
of atRA was rapidly degraded in white light, but when a band filter eliminating wavelengths 
below 500 nm was used, the degradation was negligible. Filtering of microscope light was used 
by Kane et al [57], but is not mentioned in the majority of  publications. In addition to their 
instability in light, retinoids are also thermo labile, degrade in the presence of strong acids, and 
oxidise relatively easily upon exposure to oxygen.  
When preparing embryos for analysis in the work described in this thesis, embryos were snap 
frozen in liquid N2, homogenised in small Eppendorf vials using a motorised homogeniser with 
disposable tips, and the proteins quickly denaturated with acetonitrile. The highly controlled 
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production of the active metabolite RA in vivo is likely to rely on the separation in space of 
substrates, like ROH and RAL from their corresponding oxidizing enzymes. Homogenisation of 
tissues prior to analysis has the potential to bring these together and alter the distribution of 
retinoids. Conditions in which the enzymes are inactive, like low pH and low temperature, should  
thus be preferably introduced shortly after tissue homogenisation. 
Liver microsomes have been shown to contain a component that isomerizes pure RA isomers to a 
mixture of isomers [170]. The isomerization is non-saturable, non-stereo specific, and blocked by 
thiol-blocking reagents like N-ethylmaleimide (NEM), and is therefore likely to be thiol 
dependent [162]. Similar effects have also been demonstrated with glutathione (GSH) [161] [171] 
and albumin, as well as in mixtures of sodium dodecyl sulphate (SDS), and 1-dodecanthiol alone 
[162]. Lanvers at al [172] demonstrated that cell culture medium with 10 % heat deactivated 
foetal calf serum (FCS) alone, isomerizes single RA isomers into a mixture of isomers and that, 
additionally, atRA was much more efficiently taken up into the HL-60 cells than other isomers, 
thereby driving the chemical thiol-dependent isomerization reaction further. Schmidt [172] 
detected a peak co-migrating with 9cRA in human plasma that was caused by isomerisation from 
other RAs; the degree of isomerisation was ~7 % and the plasma matrix needed to be present for 
isomerisation to occur [56]. Kane et al demonstrated that contamination by acids, in addition to 
light exposure, will also cause isomerisation and samples displaying more than 10-15 % 
isomerisation should be discarded [57]. 
Internal standards (ISs) can be used to reveal and compensate for isomerisation caused by all 
these reasons. In Paper I we used a non-retinoid as IS as a retinoid IS was not available. This IS 
functioned as a volumetric IS. In Paper II we used all-trans-9-(4-methoxy-2,3,6-
trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraen-1-ol  (TMMP-ROH) as IS. This IS could not 
reveal isomerisation of RAs, as the isomers of retinols are not fully resolved in this system. 
Analysis of pure standards and plasma/serum indicated, however, that isomerisation had not 
occurred. In Paper III we used 13c-acitretin as IS. This aromatic retinoid behaves very similarly 
to the RAs, and isomerisation during analysis can be revealed. This IS (or another isomer) has 
also been used by others [56,173].  
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In Paper IV we applied a stable isotope of atRA as IS. This is the ideal IS for RA analysis, and 
any isomerisation during analysis will be revealed. This IS can be considered to behave 
identically to atRA, also with respect to possible enzymatic isomerisation. The use of MS/MS 
and a mass slightly different from atRA provides excellent control of isomerisation in every 
sample analysed.  In Paper IV, figure 3, the plasma chromatograms clearly show that the added 
IS is not isomerised. Others have attempted to apply a stable isotope of RA as IS, but without 
success [174]. Kane at al also used MS/MS and a synthetic analogue of RA, 4,4-dimethyl-RA 
[57]. Experiments demonstrated that this IS behaved similarly to atRA when isomerisation was 
initiated by light or acid exposure. 
Extraction of retinoids 
Simple, fast and mild, monophase extraction (MPE), in combination with on-line concentration 
and clean up, is the basis for all methods and applications in this thesis. There are several benefits 
from this approach, but also drawbacks. The retinoids are a family of substances with polarity 
ranging from very apolar, and hence lipophilic, REs, to the water-soluble RAs and sugar or 
amino acid conjugated retinoids. Extracting retinoids from both ends of the polarity scale, and 
with simultaneous high recovery, is truly challenging. The methods described in Papers I, II and 
III are based on automated on-line SPE on short HPLC columns, in combination with column 
switching. In the original publications by Roth et al [163] addressing on-line SPE, it was stated 
that most drugs could be extracted with high recovery from unmodified bio-fluids. However, as 
most retinoids, except the sugar and amino acid conjugates, are incorporated into transport 
proteins (~99 % protein bound), release from the protein must be accomplished before extraction 
can take place efficiently [175]. In Paper I this was achieved by addition of 20 % acetonitrile. 
Addition of < 20 % organic modifier leaves the proteins in an altered conformation, loosening the 
protein-retinoid binding and increasing recovery on the SPE column, but still retaining the 
retinoid in solution by its interaction with the protein.  Wyss et al [176]  experienced problems 
with isomerisation caused by prolonged exposure to acetonitrile as the prepared samples queued 
up in the automated sample injector [176]. We circumvented this problem in Paper I by applying 
robotized addition and mixing of the acetonitrile and IS shortly before every injection.  
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In combination with this sample preparation we examined several 5 μm/100 Å particle 
commercial guard columns with 2 μm steel frits for use as the SPE column. None of them 
performed satisfactorily and the problems encountered were mainly low recoveries, low sample 
capacity, memory effects and rapid pressure build-up allowing only a few injections. Better 
results were achieved with a 20 mm x 4.6 mm poly ether ether ketone (PEEK) column with 2 μm 
titanium frits packed with a 30-50 μm C18 material with 300 Å pores. With this SPE column 
>200 injections of 1000 μL could be injected on the same column with 79-86 % recovery for all 
retinoids before extensive pressure build-up enforced column change. This was 4-6 times the 
number of injections reported by Wyss et al on similar systems [165,177]. In addition, use of 
titanium frits and a titanium needle in the injector reduced the memory effects obtained with their 
steel counterparts to 20 %, and therefore a complicated back-flush system to clean the SPE 
column, and used during development (not shown), was no longer necessary.  
The mobile phase (M1) bringing the injected sample through the SPE column had a physiological 
pH to avoid precipitation of proteins and clogging of the SPE column, as well as facilitating 
phase transfer of the lipophilic retinoid through the aqueous M1 to the SPE phase. It was 
however, observed that recoveries were higher when an acidic pH was used and that 
trifluoroacetic acid (TFA) performed better than acetic acid. Equally important as trapping 
retinoids efficiently, is achieving transfer of the extracted retinoids to the separating column in a 
small volume, resulting in narrow peaks and improved sensitivity. Furthermore, it has to be 
considered that the chromatographic front, caused by elution of nonretained solvents, polar 
compounds and pressure changes during injections, is often more pronounced in column 
switching and can preclude the quantification of early eluting compounds. The uncapped C18 
material used in the SPE column is rich in residual silanol groups, assumed to be important for 
high recovery of substances with hydrogen donor/acceptor functionalities. These R-Si-OH groups 
are ionisable and the pKa is 3-4. When acidic acid or formic acid is used in M1, residual silanol 
groups on the SPE column will probably be of both forms, resulting in a broader front as well as 
broader chromatographic peaks. Adjusting the separating mobile phase (M2), by exchanging 
some of the acetonitrile for methanol (MeOH) and increasing the concentration of ammonium 
acetate and using TFA in M1, resulted in narrower chromatographic peaks and a less distorted 
elution front. By monitoring the effluent from the pre-column during concentration and clean up 
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with a second UV detector it was found that a duration of ten minutes was optimal to obtain a 
clean extract with high recoveries of all retinoids.  
As an alternative to only partial denaturation of proteins prior to SPE, an excess amount of water-
miscible organic solvents like MeOH, EtOH, propanol (PrOH) or acetonitrile can be added. 
Under these conditions the conformation of the protein is significantly altered, liberating the 
retinoid and leaving the protein in a non-soluble form. Two-three volumes are needed for near 
quantitative precipitation of proteins [178]. As the lipids are no longer retained in solution by 
protein binding, it is important that the lipids to be extracted are soluble in the new composition 
of the monophase (MP).  When the sample is centrifuged, a protein pellet should form at the 
bottom of the vial, with a MP above containing all the retinoids.  
The volume and composition of the MP can be designed to optimize recoveries for the various 
different retinoids. This type of extraction is called MPE or direct extraction. In MPE the sample 
is diluted, whereas in traditional liquid-liquid extraction (LLE) the sample is often concentrated 
by evaporation. Evaporation of aqueous solutions usually requires temperatures incompatible 
with the thermo labile nature of retinoids. 
In Paper II we used MPE in combination with on-line SPE. The high organic content of the MP 
limits the volume that can be injected onto the SPE without causing broadening of the 
chromatographic peaks. By on-line dilution with water, prior to a 2.1 mm id SPE column with 5 
μm PAT frits, 2 ml MP could be injected with a resultant 97-100 % recovery of the retinoids. The 
small elution volume from the narrow SPE column, in combination with the large volume 
injected resulted in a significant concentration of the sample. Problems previously encountered of 
isomerisation on storage in the injector when all plasma components were present were not 
observed, and this concurs with the finding that sulphydryl containing proteins, like albumin and 
GSH, might induce isomerisation of retinoids [162,171]. Although even more complex 
instrumentation was needed, the combination of MPE and on-line SPE increased recoveries, 
improved sensitivity and provided a more robust and flexible routine methodology. The 
combination of large volume injection and narrow columns increased the sensitivity 
considerably.  
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In Paper III MPE was used, but dilution with water after centrifugation was performed off-line, 
followed by injection of 1000 μl onto the SPE column. This was mainly due to limitations in 
available instrumentation. Recoveries were in the range of 86-103 % for ROH and RA isomers. 
When developing the method described in Paper IV, we wanted to keep the simple MPE as it is 
very gentle and there is no risk of losing retinoids with high polarity into the water phase as 
occurs with two phase LLE. There is also no need to adjust the pH by addition of alkali or acids 
in MPE. The column switching based SPE system functions well, but it is complicated, and as the 
SPE column ages there is a risk that extraction recovery might be affected. It would therefore be 
advantageous if the SPE step could be avoided. There was also a real need for a fast method with 
a capability of handling large numbers of samples in a short time. By applying APCI-MS/MS in 
positive multiple reaction monitoring (MRM) mode we achieved a sensitivity and selectivity that 
allowed direct injection of 100 μL of EtOH-based MPE, allowing quantification of the important 
retinoids in plasma. To avoid peak distortion of early eluting retinoids, it was necessary to 
perform on-column focusing. This was achieved by using 75 % water in acetonitrile (0.1 % 
formic acid) as the initial conditions in the elution gradient.  Recoveries were in the range of 87-
105 % for ROH and RA isomers.  
Separation of cis trans isomers of retinoids 
We have developed rapid methods on specialty phases for separating geometrical isomers of 
retinoids. Most retinoids can exist in between 3 and 5 different geometrical cis trans isomers (see 
fig 1 in Paper V).  Altogether several hundred different retinoids are possible. Separation of all 
retinoids, including the various isoforms, in the same run is not possible with HPLC, and rarely 
necessary, as only a few retinoids are normally present in the same type of sample. The most 
frequently used reversed phase (RP) columns, are the classical C8, C18 or C30 type columns. 
Separation of retinoid isomers often requires time-consuming gradient elution: However by using 
the chemical features of the various retinoid molecules, and by exploring different specialty 
stationary phases for chromatography, we are now able to manipulate their retention. 
Additionally, understanding these chemical interactions has enabled us to achieve the required 
separations in a shorter time. To achieve the lowest possible detection limits in trace analysis by 
UV detection or ED, it is advantageous to use isocratic separation. Isocratic separation of RA 
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geometrical isomers has been reported on a few types of column materials. The Suplex pKb-100 
column (Supelco, Bellafonte, USA), used for most of this work, separates RA isomers 
remarkably well under isocratic conditions, and has been used by several groups for this purpose 
with excellent results [134,166,179-183]. The material has an amide functionality incorporated 
into the alkyl chain, close to the silica back-bone. This polar moiety probably forms strong 
secondary interactions with the polar end group of the retinioids. As a result, the retention of 
retinoids is stronger than that of other sample constituents, and high selectivity for retinoids has 
been achieved. Resolution between the geometrical isomers is probably due to this, combined 
with different degrees of hydrophobic interaction between the stationary phase alkyl chain and 
the polyene chain of the retinoid. Cis isomers have a shorter chain, and will therefore have less 
overlap in comparison to the all-trans isomer. A similar column, Supelcosil ABZ+Plus, was 
recently used by Kane at al [57]. In Paper IV another type of column was used. This method was 
designed for high-throughput analysis of polar retinoids in plasma. 
High-throughput HPLC 
In order to analyse a large number of samples in a short time, we have developed high-throughput 
methodology (Paper IV) for retinoid analysis. Also with MS/MS detection geometrical isomers 
have to be separated in time as the isomers fragmente in very similar fashion. The 
chromatographic separation time can be reduced by either increasing the flow rate and/or by 
shortening the length of the analytical column. There are two types of high-throughput HPLC 
columns, monolithic columns with very low backpressure at high flow rates, and short columns 
with smaller sized particles, typically 1-3 μm. Sub two micron columns will often generate very 
high backpressures at high flow rates. To handle this elevated pressure, ultra high pressure 
HPLC, or ultra performance liquid chromatography (UPLC) was introduced in 2004 [184]. We 
have used columns packed with 1.8 μm particles, in combination with high flow and high 
temperature. A high temperature is used to decrease the viscosity of the mobile phase, which 
consequently reduces the backpressure. Separation of the important geometrical isomers was 
achieved in 6 minutes. 
When large number of samples are analysed, the second bottleneck is sample preparation. 
Previously we have used on-line sample preparation techniques in sequential mode. This means 
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that the total sample preparation time can be calculated as individual sample preparation time 
multiplied by the number of samples (e.g. 1000 samples x 10 min =  7 days). In Paper IV sample 
preparations were performed in parallel, in microtiterplates for up to 200 samples. This reduces 
the time spent on sample preparation significantly. Compared to classical approaches, like LLE 
or off-line SPE, this is a major improvement, facilitating the analysis of a large number of 
samples with little technical assistance necessary. The very short total analysis time is also 
advantageous for maintaining the integrity of the labile retinoids. 
Detection of retinoids in chromatographic systems 
In the methods and applications described herein, we have used UV detection in the form of 
single wave detectors and DAD. In Papers III and VII we have applied coulometric ED. On 
several occasions we have applied MS for qualitative purposes and in Paper VIII tandem MS was 
used for quantification as well. 
UV and fluorescence detection (FLD)
We used UV as the primary detection technique in Papers I, II and VI. Most retinoids absorb UV 
light strongly in a region of the spectrum (300-400 nm) where few other natural compounds 
absorb light. Detection based on this technique is, in many cases, superior and is used in the 
majority of publications dealing with quantitative retinoid analysis [56,185,186]. The normal 
bore chromatographic system in Paper I generated a limit of detection (LOD) of around 2 ng/ml. 
When using the narrower columns in Paper II, the mass limits of detection (mLOD) for atRA was 
60 pg on-column. In additional papers not included in this thesis, the candidate, in collaboration 
with others, explored further possible benefits of reducing the inner diameter to capillary 
dimensions (320 μm) in combination with on-line SPE and column switching [166,167]. The 
mLOD was 0.9 ng for retinyl palimitate [167] and 5 ng  for atRA [166]. In comparison Wyss et al 
[173] reported mLOD of 50 pg for atRA  while Schmidt [56] obtained a mLOD of 30 pg on-
column for atRA. 
Electrochemical detection (ED)
In Papers III, VII and VIII we used on-line SPE with coulometric ED for detection of RAs and 
ROH in embryonic tissue. ED is a potentially sensitive and selective technique, but it is rarely 
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applied for the determination of retinoids. The polyene chain of retinoids will be oxidized at a 
sufficiently high positive potential in amperiometric, as well as coulometric, EDs. A few methods 
using liquid chromatography (LC)-ED for determination of retinoids have, however, been 
reported. Hagen et al [187] describe a method for separating and detecting retinoids by reverse-
phase capillary liquid chromatography with amperiometric ED. Detection limits of 410, 64.1, 
60.9, and 38.2 pg/ml for 13cRA, atRA, RAL, and ROH, respectively, were reported. The mLOD 
were 10 pg and 25 pg for the RAs and atROH, respectively. ED has also been used for retinoid 
detection by others [188-194]. 
Mass spectrometric detection (MS)
We have used MS in Papers VII and VIII for qualitative purposes, as well as as a quantitative 
detection technique in Paper IV.  The combination of LC and MS (LC-MS) provides a powerful 
analytical technique that combines the resolving power of HPLC, with the potentially high 
specificity and low LOD of MS. Historically only a handful of papers describe the use of LC-MS 
for the determination of retinoids in biological samples [195-198]. During the last decade, 
however, modern soft atmospheric pressure ionisation techniques like electrospray ionisation 
(ESI) and APCI have been explored for retinoid analysis. During recent years, hyphenated 
techniques like tandem MS (MS/MS), have also been available. 
In Paper IV a method using positive ion APCI coupled to tandem MS detection (LC–MS/MS) 
was developed for the determination of at4oxoRA, 13c4oxoRA, 13cRA, atRA and atROH in 
human plasma using a stable isotope of atRAas the IS. The Applied Biosystem API 4000 Qtrap 
tandem mass spectrometer, equipped with a heated nebuliser (APCI) ionisation source, was 
operated in multiple reaction monitoring (MRM) mode, with the precursor-to-product ion 
transitions m/z  315.4ĺ 297 (4oxoRAs), 301.2 ĺ 205 (RAs), 305.0 ĺ 209 (IS) and 269.2 ĺ 93 
(ROH) used for quantification. The assay was fully validated and was found to have acceptable 
accuracy, precision, linearity, sensitivity and selectivity. The limit of quantification was in the 
range of 0.1-0.3 ng/ml andthe mLOD in the range 1-4 pg on-column. APCI was selected instead 
of ESI as ion suppression was less pronounced. Ion suppression will reduce the sensitivity of the 
assay as well as limit assay reproducibility and can be a serious problem in quantitative LC-MS 
analysis. Problems and solutions regarding ion supression/matrix effects in LC-MS have been 
discussed in several recent papers [199-202]. 
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LC-APCI-MS/MS operated in MRM mode  was used by Napoli and co-workers for RA analysis 
in adult mouse brain [57]. ROH and RE were removed by LLE during a rather extensive sample 
clean up before LC-MS/MS analysis. The assay allowed quantification of 6 pg atRA on-column 
(0.3 ng/ml). Wang et al [203] used a less selective, single-stage MS in positive single ion 
monitoring mode with APCI for the quantification of ROH and RA in rat prostate tissue. The 
sample preparation consisted of evaporation and reconstitution of an ethanolic supernatant 
resulting from protein precipitation.  The method allowed quantification of 211 pg RA and 0.6 ng 
ROH on-column. Matrix effects were not studied. It is, however, rather supprising that the 
finding of massive amounts of 9cRA and 9cROH was not given more notice. A similar sample 
preparation was used by Rühl [204] in combination with MS/MS detection (triple quadrupole). 
The ethanolic supernatant was, in this case, concentrated by vacuum centrifugation and a LOD of 
7 pg on-column was reported.  In earlier publications Van Breemen and co-workers [205,206] 
used ESI-MS in positive mode for measuring ROH and RAL, and ESI in negative mode for RA, 
as well as positive APCI-MS for atROH and at-retinyl palmitate. ESI generated detection limits 
for RA, RAL and ROH of 23 pg, 1.0 ng and 0.5 ng, respectively, whereas APCI gave mLOD of 
0.670 pmol atROH and 0.720 pmol at-retinyl palmitate on-column. 
MS/MS, in the form of an iontrap mass spectrometer, has been used for the characterisation of 
14-hydroxy-retro-retinol and 4-hydroxyretinol in the liver of neonatal rats at days 3 and 11 after 
birth, and the novel retinoid 9-cis-4-oxo-13,14-dihydro-RA in adult mouse liver and also in 
human liver [207]. Others have used normal phase LC-APCI-MS/MS (iontrap) for quantification 
of ROH and RA in liver from 8-week old rats and retina from embryonic mice on days 13-15 
[174]. The lower limit of detection was 50-100 fmol on-column. The concentration of liver ROH 
in three different animals was 13.3, 22.4 and 16.6 nmol/g, and that of RA was 1.0, 1.9 and 2.2 
nmol/g. atRA concentrations in mouse retina were found to be 20.8 (s.d. 2.0) pg/μg retina protein. 
Matrix effects were not discussed, but the authors found that use of a stable deuterated isotope of 
atRA as an IS caused larger variations than when no IS was used. When soft ionisation 
techniques are used, there is a real risk of overloading the ionisation capacity in the spray 
chamber and an IS can be very helpful. In Paper IV, we have successfully applied a novel 13C
(10,11,14,15-13C-at RA)-labelled stable isotope of atRA. In spite of the very simple preparation, 
and three times dilution of the samples, the detection limits of the method described in Paper IV 
are comparable to, or even better than, other methods.  
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Unequivocal identification of retinoids 
Identification of retinoids found in biological samples has, in work included in this thesis, been 
performed by matching chromatographic retention with pure standards, by recording of on-line 
UV spectra and comparing these with spectra from pure standards, and by MS and tandem MS. 
Unequivocal identification of a specific retinoid by chromatographic techniques is not an easy 
task. There is a multitude of possible retinoids, and the number of commercially available 
authentic retinoid standards is very limited. The analytical chemist can obtain these as gifts from 
other researchers or institutions, isolate them from natural sources, or synthesise them. The 
subsequent utility of this retinoid is therefore highly dependent on full initial characterisation of 
the molecular structure, something that is not always performed, or at least the data may not be 
available to researchers. Ideally, a certificate stating the identity and purity should accompany the 
retinoid, as for commercial standards. A thorough spectral characterisation should include high-
resolution MS, nuclear magnetic resonance (NMR) and UV spectroscopy. If a pure authentic 
standard is available, matching the chromatographic retention time of an unknown in a specified 
system with that of a standard is an indication, although not proof, of its identity. Further 
identification can be done by collecting the fraction containing the substance and re-injecting it 
on a second chromatographic system, then again comparing the retention of the standard with the 
unknown. This is, of course, not possible when using destructive detectors like ED and MS.   
Many retinoids absorb strongly in the 300-400 nm region of the UV spectrum, where few other 
substances do. However, as the concentrations of bioactive retinoids are extremely low, there is 
often substantial noise at the baseline. Thus, UV spectra of endogenous concentrations of 
retinoids collected on-line with DAD, if visible at all, often lack the quality needed for 
identification purposes. Single quadrupole MS seems to be less selective for retinoids compared 
with UV. This is especially true when ESI is used. APCI is, in general, a more selective 
ionisation technique and will generate cleaner chromatograms. MS/MS detection is very selective 
and provides increased specificity compared with UV detection of retinoids. Unequivocal 
identification of the geometrical form of a retinoid isolated from biomaterial can, however, only 
be obtained with NMR. Because the amount of substance needed for NMR is relatively high, and 
the endogenous amounts of retinoids are very low, this is rarely feasible. NMR can also be 
performed on-line with HPLC. HPLC-NMR is starting to become available in some labs, and has 
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been used for the structural characterisation of some retinoids [208-211]. Some, or several, of 
these approaches are often used during method development and validation of assays. For 
practical reasons, however, it is less common to apply full qualitative analysis to every sample, 
even when analysing different kind of tissue. There will always be a risk that new interferences 
appear in some samples or in different types of tissues and the amount of interfering substances 
might also change and lead to falsely low or elevated results. 
Variations in the retention behaviour of similar chromatographic columns or even between 
batches of the same type of column have been reported. For example, Noll et al recently revealed 
extensive inconsistencies and errors in the elution order of retinal and retinol isomers in straight 
phase chromatographic systems [212].  
Retinoids and embryological development in mice and chickens 
In Papers VI, VII and VIII the methods developed in this thesis have been applied to study the 
role of retinoids in embryonic development mice and chickens.  
In Paper VI the developing eye of the chicken was studied. In addition to the common retinoids 
ROH, RAL, RE and RAs, the chicken has a second set of retinoids, namely the 
didehydroretinoids (Vitamin A2). Vitamin A2 standards were obtained from F.Hoffmann-La 
Roche Ltd and Dr. Anders Vahlquist and the method described in Paper II was adapted to include 
these retinoids. Epithelium, choroid and sclera (stages: E8.5, E7.5, E6.5 and E4.5) were isolated 
from chick eyes at different stages of development and analysed for retinoids. The whole eye was 
also analysed at the earlier stage (E4.5).  RAs and their precursor ROHs were found to be the 
predominant retinoids in the developing chick eye. AtRA and all-trans-3,4-didehydro-RA were 
present in the neuroepithelium in approximately equal amounts from early stages of neurogenesis 
until shortly before hatching. The RXR ligands 9cRA and 9c4oxoRA were not detected at any of 
these stages. RAs were not detected in the pigment epithelium at all. AtROH was present in the 
neuroepithelium and pigment epithelium, whereas all-trans-3,4-didehydro-ROH was detected 
only in the pigment epithelium and/or the choroid and sclera. These results demonstrated spatial 
distinctions in retinoid synthesis and signalling, that may be related to laminar differentiation in 
the developing retina.  
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In Paper VII developing mice were examined for retinoid content. Whole embryos from stages 
9.5 dpc, 8.5 dpc, 7.5 dpc and 6.5 dpc were analysed for 16 different retinoids. Only atRA, atROH 
and atRAL were detected at the various stages. atRA and at-retinol were detected at 9.5, 8.5, 7.5 
dpc, but not at 6.5 dpc. However, at this stage, and at stage 7.5 dpc, its precursor atRAL was 
present. The method described in Paper III was used for quantitative analysis. A similar system, 
with DAD, was used for retinoid identification. In addition, LC-MS was used to confirm the 
identity of RAL at the earlier stages. Prior to this publication, no chemical analysis data existed 
on stages earlier than 9.0 dpc. The novel finding of RAL at the early stages of development, 
together with the detection of RALDH2 (also Paper VI, RT-PCR) and atRA at stage 7.5 dpc, 
indicates that it is at this stage that RA signalling becomes active in the developing mouse and 
that RALDH2 is the key regulator. 
In Paper VIII regions of the mouse spinal cord were studied. This publication was the first to 
describe the quantitative profile of specific endogenous retinoids along the axis of the developing 
mouse spinal cord. Following an intriguing publication by Solomin et al [213], where strong 
evidence for the presence of RXR activation was demonstrated in different regions of the mouse 
spinal cord at stage 10.5 dpc, we dissected these regions from mouse embryos to determine 
whether 9cRA occurred there, but could only detect atRA. Only after the mother was fed large 
toxic amounts of atRA, could small amounts of 9cRA be detected, together with several other 
retinoids including 13cRA and 13c4oxoRA. Although no comparable specific quantitative data 
obtained by chemical analysis are available, our findings are supported by data obtained by other 
techniques. Bioassays and reporter mice have demonstrated the presence of retinoids in the 
developing neuroaxis, including the spinal cord, with concentrations at lumbar and brachial levels 
relative to thoracic levels [213-218]. 
The physiological role of 9-cis retinoic acid is questionable 
Following the original publication in January 1992 demonstrating that 9cRA acts as a ligand for 
the RXRs [219], more than a thousand investigations have been published establishing the potent 
effects of this compound in numerous biological processes. It is now generally accepted that 
9cRA represents one of the signalling pathways that comprise the mechanisms of action of ROH. 
However, a major premise for this biological role remains unconfirmed and has been largely 
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neglected by the research community: that is, the unequivocal identification of 9cRA as an 
endogenous compound. Although only a few applications are presented in this thesis, the 
methodology presented herein has been applied to a multitude of sample types from many species 
of animals and we have never detected endogenous 9cRA in any tissue sample, unless high toxic 
amounts of retinoids have been administered. 
By using the ultra-sensitive HPLC method described in Paper III we detected ample amounts of 
atRA, but no 9cRA, in any region of the mouse embryonic spinal cord. We could only 
demonstrate 9cRA in mouse embryos when massive, teratogenic doses of RA were fed to the 
pregnant dams. We also tried to reproduce the original identification of 9cRA in mouse kidney 
and liver [219], but were unable to detect 9cRA in normal mouse kidney or liver, nor in human 
plasma. Furthermore, polar bear liver, which is known to accumulate near toxic amounts of 
vitamin A, contains many different retinoids but not 9cRA (data not shown). We have also, in 
collaborative projects not referred to in this thesis, examined: plasma from rats, salmon, dogs, 
and monkeys, and tissue samples from rats, monkeys and dogs without detecting 9cRA. Thus, 
demonstration of 9cRA has to date only been tentatively demonstrated in humans following 
administrations of about 100 mg vitamin A [220] and in mice embryos after maternal ingestion of 
toxic, teratogenic doses of atRA [180]. 
Should we then conclude that 9cRA is only present during vitamin A intoxication and 
teratogenicity? Although this might be the case, it may be wise to defer such a conclusion at 
present. Firstly, 9cRA might only be present in very localized regions, or in very few cells, but at 
concentrations that are high enough to drive a biological response (about 1 nM). Secondly, 
detection of 9cRA could be missed because sufficient concentrations are only present transiently. 
As it is documented that RXR signalling does occur [221,222], ligands other than 9cRA might be 
responsible. In fact, phytanic acid, eicosanoids and docosahexaenoic acid (DHA), have been 
shown to activate RXRs [223-225] 
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CONCLUSIONS 
We have developed a set of chromatographic methods for the quantititative and qualitatative 
identification of a number of retinoids in minute amounts of various biological samples. The 
methods have been specially designed to preserve the very labile retinoids.  To minimize the risk 
of artifact formation of geometrical isomers, a simple protein precipitation and MPE in containers 
protected from light has been the basis for all the methods used. Further treatment, like clean up, 
concentration, separation and detection have been automated in multidimensional HPLC systems 
with various detectors. The methods used have high resolving powers, ultra high sensitivities and 
full protection from critical variables at all times.  Paper IV represents state-of-the-art 
methodology, and includes increased sensitivity, real-time control of possible isomerisation, and 
high-throughput capabilities by implementing LC-MS/MS technology, stable retinoid isotopes, 
and sub two micron HPLC columns for fast separation of geometrical isomers. 
The developed methods have been applied to several challenging projects, studying important 
biological functions during embryonic development of retinoids in mouse and chicken. As a 
result of the increased sensitivity and optimal control of possible artifact generation during 
analysis, several novel findings have been possible. These include: identifying atRAL and the 
onset of RA signalling at 7.5 dpc in the developing mouse embryo; demonstrating the lack of 
9cRA in regions of the mouse spinal cord where RXR signalling is known to occur; obtaining the 
first quantitative profile of specific endogenous retinoids along the axis of the developing mouse 
spinal cord; defining the spatio-temoral distribution of endogenous retinoids in several regions of 
the developing eye of the chicken.  
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